The Royal Treatment: Year's Largest IPO Royalty Pharma Soars 58.9% In First Day Of Trading

The Royal Treatment: Year's Largest IPO Royalty Pharma Soars 58.9% In First Day Of Trading

SeekingAlpha

Published